Alzheimer's Drugs Industry Analysis Report: Key Trends, Drivers, and Forecast Insights

 Offering reliable and timely data, this report is a key resource for anyone building or refining their alzheimer's drugs industry roadmap.


How Large Will The Alzheimer's Drugs Market Be By 2025?
The alzheimer's drugs market size has grown strongly in recent years. It will grow from $9.33 billion in 2024 to $10.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rise in Alzheimer’s disease cases, investments in research and development, improved understanding of disease mechanisms, global health initiatives, public awareness and education.

The alzheimer's drugs market size is expected to see strong growth in the next few years. It will grow to $14.16 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to precision medicine approaches, focus on disease modification, biomarker identification and validation, patient-centric drug development, focus on non-pharmacological interventions. Major trends in the forecast period include diverse therapeutic approaches, digital health solutions, regenerative medicine, advancements in diagnostic technologies, artificial intelligence (AI) in drug discovery, partnerships and collaborations.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp

What Are Key Factors Driving The Demand In The Global Alzheimer's Drugs Market?
The rising prevalence of Alzheimer's disease is expected to propel the growth of the Alzheimer's drugs market going forward. Alzheimer's disease is a neurologic condition that worsens over time and causes both brain shrinkage and cell death. Drugs for Alzheimer's disease are used to treat memory loss, problems with thinking and reasoning, and difficulties with everyday living. Drugs for Alzheimer's can enhance the quality of life and help maintain independence. For instance, in May 2024, according to a report by the Alzheimer’s Association, a US-based nonprofit organization dedicated to Alzheimer's care, support, and research, the number of Americans aged 65 and older diagnosed with Alzheimer's dementia rose from 6.5 million in 2022 to an estimated 6.9 million in 2024. Therefore, the increasing prevalence of Alzheimer's disease is driving the growth of the Alzheimer's drugs market.

Comparative Analysis Of Leading Alzheimer's Drugs Market Segments
The alzheimer's drugs market covered in this report is segmented –

1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages

Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules

What Are The Key Trends Shaping The Alzheimer's Drugs Industry?
Major companies in the Alzheimer’s drugs market are developing innovative products, such as amyloid plaque-targeting therapy, to advance treatment options and improve patient outcomes. Amyloid plaque-targeting therapy is a treatment approach for Alzheimer's disease that focuses on reducing or preventing the accumulation of amyloid-beta plaques in the brain. For instance, in June 2024, Eli Lilly and Company, a US-based pharmaceutical company got approval for Kisunla (donanemab-azbt) from the Food and Drug Administration (FDA), a US-based federal agency for protecting public health. Kisunla (donanemab-azbt) is the first and only amyloid plaque-targeting therapy for early symptomatic Alzheimer's disease. It works by aiding the body in removing excess amyloid plaques from the brain, which are associated with cognitive decline in Alzheimer's patients. Kisunla is administered as an intravenous infusion every four weeks. The initial dosing regimen involves 700 mg for the first three doses, followed by 1400 mg thereafter. Kisunla is specifically indicated for adults with mild cognitive impairment (MCI) and mild dementia stages of Alzheimer's disease, provided they have confirmed amyloid pathology.

Who Are The Prominent Players In The Alzheimer's Drugs Business?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd

View the full alzheimer's drugs market report here:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report

Which Region Is Expected To Lead The Alzheimer's Drugs Market By 2025?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer’s drugs market during the forecast period. The regions covered in the Alzheimer’s drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

#Contact Us:#

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


#Follow Us On:#

LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. How has the ammonia grown historically, and what trends indicate future expansion? The ammonia market size has grown strongly in recent years. It will grow from $79.13 billion in 2024 to $85.57 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to agricultural demand, expanding population, energy and power generation, chemical manufacturing:. The ammonia market size is expected to see strong growth in the next few years. It will grow to $124.86 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to hydrogen economy development, renewable energy, carbon capture and storage (ccs), clean energy transition. Major trends in the forecast period includ...
Read more

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the poultry disinfectant industry by 2029? The poultry disinfectant market size has grown strongly in recent years. It will grow from $4.67 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to demand for biosecurity and disease prevention, growth in poultry farming and agriculture, expansion of food safety regulations, use in hatcheries and broiler farms, regulatory standards for poultry hygiene. The poultry disinfectant market size is expected to see rapid growth in the next few years. It will grow to $7.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to sustainable and eco-frie...
Read more

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies

 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Ammonium Sulfate industry. What is the projected value of the ammonium sulfate market by 2029? The ammonium sulfate market size has grown strongly in recent years. It will grow from $3.88 billion in 2024 to $4.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to economic growth, agriculture demand, government subsidies, population growth, rise in chemical industry. The ammonium sulfate market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing crop yields, environmental regulations, food security concerns, rising pharmaceuticals sector, rise in disposable income. Major ...
Read more